GLENMARK PHARMACEUTICALS LTD.

In News

Glenmark Pharma stock jumps 2% after USFDA clears Monroe facility; here are target prices - MSN

MSN - Jan 08, 2026

Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial - PR Newswire

PR Newswire - Nov 04, 2025

India's Glenmark posts higher quarterly profit on strong demand in N.America, Europe - Reuters

Reuters - Nov 14, 2025

Hengrui Pharma and Glenmark Pharmaceuticals Enter Exclusive License Agreement for HER2 ADC Trastuzumab Rezetecan (SHR-A1811) - Yahoo Finance

Yahoo Finance - Sep 24, 2025

The FDA Is Cracking Down on an Indian Drugmaker Investigated by ProPublica Last Year - ProPublica

ProPublica - Jul 28, 2025

Glenmark bags multi-regional rights to Hansoh Pharma’s oncology drug for $1 B - BioSpectrum Asia

BioSpectrum Asia - Dec 18, 2025

Glenmark Pharmaceutical Ltd ~ Ambitious Guidance or Realistic Roadmap? - Smartkarma

Smartkarma - Dec 30, 2025

Glenmark Pharmaceuticals Ltd. is Rated Strong Buy - MarketsMojo

MarketsMojo - Jan 10, 2026

In potential $1.1B deal, Glenmark grabs certain rights to Hengrui's ADC rival to Enhertu - Fierce Pharma

Fierce Pharma - Sep 24, 2025

Glenmark Pharmaceuticals : Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma - marketscreener.com

marketscreener.com - Dec 16, 2025

Getting In Cheap On Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Might Be Difficult - simplywall.st

simplywall.st - Nov 12, 2025

Generic-Drug Makers To Pay $71M To End Price-Fixing Claims - Law360

Law360 - Aug 19, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment